June 2, 2021

9:00 am / 12:00 pm Los Angeles

REGISTER TODAY! The HIV Prevention Review Meeting 2021 will take place on June 2, 2021 from 9 a.m. – 12 p.m., PST and will be virtual.

The global HIV epidemic continues to present a significant health and economic burden for nearly 38 million infected people worldwide. Despite notable progress to contain the virus spread, and a reduction of nearly 40% in new infections in the last two decades, 1.7 million new cases were reported worldwide last year alone. This is particularly of concern in certain regions, where the number of new infections has been growing rapidly. In Eastern Europe, for instance, it has grown almost 50% per year since 2010.

HIV prevention is in the midst of an exciting chapter, with several different drugs and formulations being investigated or already available to prevent HIV acquisition. This wealth of new data and knowledge, being present at the major conferences, comes hand-in-hand with a need to review the importance of these findings and their implications for the implementation of prevention programs. The Prevention 2021 review meeting aims at bridging this gap to consolidate the implications of the new data on PrEP presented at the last three conferences, and thus extrapolates the impact of the latest emerging data.

After participating in HIV Prevention Review Program 2021, participants will be able to:

  • Summarize the most important findings from recent clinical studies on HIV prevention
  • Understand the clinical data supporting novel PrEP options
  • Describe the pros and cons of different PrEP formulations
  • Reflect on the prospects for PrEP

Link to registration: https://virology.eventsair.com/hivpre2021/registration/Site/Register

Registration fee is waived for all healthcare professionals.

Event Flyer: HIV Prevention Series 2021 - Flyer